Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AST-201 by EpiThany for Ovarian Cancer: Likelihood of Approval
AST-201 is under clinical development by EpiThany and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I...